Our CBD Trials

CBD Pain Study

This is a randomised, double-blind, placebo-controlled Phase 3 registration parallel arm study to evaluate the efficacy, safety and tolerability of 60 mg Promethean Health CBD daily vs. placebo in adults experiencing mild-to-moderate pain.

This study is being conducted at our Western Sydney, Canberra, Centeral Coast and Brisbane sites.

Apply Now
Placeholder Image
Apply for future trials.
Paratus Clinical is always in need of dedicated patients who would like to contribute to answering important research questions.
If you would like to be contacted about future research opportunities, please select 'Register Now' and submit your details.
You will be contacted by a recruitment specialist shortly.